PALO ALTO, Calif.--(BUSINESS WIRE)--Sept. 12, 2006--Human BioSystems ("HBS" or "Company") (OTCBB:HBSC) announced today that a pre-IND (Investigational New Drug) application meeting with the FDA (Food and Drug Administration) has been scheduled for early October to discuss HBS's plan to conduct human infusion tests using the Company's patented platelet preservation system.
